LifeStance Health Group, Inc.
LFST- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001845257
In the last 90 days, LifeStance Health Group, Inc. insiders filed 0 open-market purchases and 9 sales; 288 institutions reported holding it in 13F filings for Q2 2026, worth $4.04B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by LifeStance Health Group, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 9 filings
- 6 insiders, $387.8M in total
- Insiders trading
- 6
- Net value
- −$387.8M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for LifeStance Health Group, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bourdon David | Chief Executive Officer | 150,000Indirect | Sep 24, 2026 | 4 |
| Coulter James G | 10% Owner | 79,691,702Indirect | Sep 15, 2026 | 4 |
| Winkelried Jon | 10% Owner | 79,691,702Indirect | Sep 15, 2026 | 4 |
| TPG GP A, LLC | 10% Owner | 79,691,702Indirect | Sep 15, 2026 | 4 |
| Paunovich Vukasin | Chief Technology Officer | 205,379 | Sep 4, 2026 | 5 |
| Varanakis Ann | Chief People Officer | 413,881 | Aug 26, 2026 | 5 |
| DeLuca Teresa | Director | 97,093 | Aug 18, 2026 | 3 |
| Burdick Kenneth A | Director | 2,970,810 | Aug 13, 2026 | 4 |
| Miller Lisa K | Chief Operating Officer | 281,289 | Aug 12, 2026 | 5 |
| Palmer Eric P | Director | 89,174 | Jul 7, 2026 | 1 |
| Bessler Robert | Director | 75,365 | Jul 7, 2026 | 9 |
| Personette Sarah | Director | 92,512 | Jul 7, 2026 | 2 |
| Justice Thurman | Director | 35,492 | Jul 7, 2026 | 1 |
| Goltermann Lori | Director | 35,492 | Jul 7, 2026 | 1 |
| Black Darren M. | Director | 23,310,115Indirect | May 14, 2026 | 2 |
| Shuey Eric | Director | 867,562Indirect | May 14, 2026 | 1 |
| Pardo Ryan | See Remarks | 1,093,366 | Apr 3, 2026 | 3 |
| McGroarty Ryan | See Remarks | 772,235 | Mar 26, 2026 | 4 |
| Eken Stephanie Carin | Chief Medical Officer | 115,107 | Mar 9, 2026 | 1 |
| Silversmith Capital Partners I-B, L.P. | Other: Member of 10% Group | 14,324,197Indirect | Aug 20, 2025 | 0 |
| Silversmith Capital Partners I-A, L.P. | Other: Member of 10% Group | 14,324,197Indirect | Aug 20, 2025 | 0 |
| Silversmith Capital Partners I-C, L.P. | Other: Member of 10% Group | 14,324,197Indirect | Aug 20, 2025 | 0 |
| Silversmith Partners I GP, L.P. | Other: Member of 10% Group | 14,324,197Indirect | Aug 20, 2025 | 0 |
| Silversmith Partners I GP, LLC | Other: Member of 10% Group | 14,324,197Indirect | Aug 20, 2025 | 0 |
| Summit Partners L P | 10% Owner | 33,524,715 | Aug 20, 2025 | 0 |
| Summit Partners Growth Equity Fund IX-A, L.P. | Other: shareholder | 33,524,715 | Aug 20, 2025 | 0 |
| Summit Partners Growth Equity Fund IX-B, L.P. | Other: shareholder | 33,524,715 | Aug 20, 2025 | 0 |
| Summit Investors Ge IX/VC IV, LLC | Other: owner | 33,524,715 | Aug 20, 2025 | 0 |
| Summit Partners Entrepreneur Advisors Fund II, L.P. | Other: Owner | 33,524,715 | Aug 20, 2025 | 0 |
| Summit Investors Ge IX/VC IV (UK), L.P. | Other: Owner | 33,524,715 | Aug 20, 2025 | 0 |
| Ramtekkar Ujjwal | Chief Medical Officer | 103,916 | Jun 18, 2025 | 0 |
| Pantaleoni Pablo | Chief Digital Officer | 915,301 | May 19, 2025 | 0 |
| Miller William Joseph | Director | 459,880 | Aug 27, 2024 | 0 |
| Verma Seema | Director | 137,811 | Aug 27, 2024 | 0 |
| Qureshi Danish J. | See Remarks | 439,002Indirect | Jun 18, 2024 | 0 |
| Mullins Kevin Michael | Chief Development Officer | 4,650,571 | Jun 13, 2024 | 0 |
| Summit Investors Management, LLC | Other: Manager and GP of 10% Owner | 41,932,358Indirect | May 29, 2024 | 0 |
| Summit Master Company, LLC | Other: Manager of GP of 10% owner | 41,932,358Indirect | May 29, 2024 | 0 |
| Summit Partners Ge IX, LLC | Other: GP of 10% owner | 41,932,358Indirect | May 29, 2024 | 0 |
| Summit Partners Ge IX, L.P. | Other: GP of 10% owner | 41,932,358Indirect | May 29, 2024 | 0 |
| Summit Partners Entrepreneur Advisors GP II, LLC | Other: GP of 10% owner | 41,932,358Indirect | May 29, 2024 | 0 |
| Bonderman David | 10% Owner | 160,711,618Indirect | May 29, 2024 | 0 |
| Crisan Jeffrey | Director, Other: Member of 10% Group | 17,916,554Indirect | May 29, 2024 | 0 |
| Cipollone Paula | See Remarks | 239,915 | May 14, 2024 | 0 |
| Gouk Warren | Chief Administrative Officer | 5,818,204 | Sep 5, 2023 | 0 |
| Patel-Dunn Anisha | Chief Medical Officer | 277,055 | Jun 29, 2023 | 0 |
| Lester Michael K. | President and CEO | 23,148,931 | Jun 14, 2022 | 0 |
| Booth Gwen H. | Chief Operating Officer | 7,083,637 | Jun 14, 2022 | 0 |
| Gorcyca Felicia | Chief People Officer | 909,582 | Jun 14, 2022 | 0 |
| Bruff Jesse Michael | Chief Financial Officer | 1,928,369 | Apr 26, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 (view filing) | Mar 14-15 | 2 days | Bruff Jesse MichaelChief Financial Officer | SSale | −18.5K | $7.92 | −$146.5K | −1.0%1.82M after | 2 lots |
| Apr 22, 2022 (view filing) | Apr 20 | 2 days | Mullins Kevin MichaelChief Development Officer | SSale | −46.3K | $10.68 | −$494.3K | −0.8%5.67M after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Lester Michael K.President and CEO | SSale | −328.6K | $5.33 | −$1.75M | −1.4%23.1M after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Gorcyca FeliciaChief People Officer | SSale | −2.64K | $5.33 | −$14.1K | −0.3%909.6K after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Booth Gwen H.Chief Operating Officer | SSale | −88.8K | $5.27 | −$468.0K | −1.2%7.08M after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Mullins Kevin MichaelChief Development Officer | SSale | −78.9K | $5.30 | −$417.9K | −1.4%5.67M after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Qureshi Danish J.Chief Growth Officer | SSale | −85.9K | $5.32 | −$456.9K | −1.9%4.34M after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Pardo RyanSee Remarks | SSale | −56.4K | $5.35 | −$301.6K | −10.1%500.7K after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Patel-Dunn AnishaChief Medical Officer | SSale | −3.46K | $5.34 | −$18.5K | −3.5%94.7K after | |
| Jun 22, 2022 (view filing) | Jun 9 | 13 days | Gouk WarrenChief Administrative Officer | SSale | −10.0K | $7.32 | −$73.2K | −0.2%6.27M after | Amended |
| Aug 5, 2022 (view filing) | Aug 3 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −68.9K | $7.00 | −$482.3K | −1.1%6.20M after | |
| Aug 10, 2022 (view filing) | Aug 8 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −17.2K | $7.30 | −$125.7K | −0.3%6.18M after | |
| Aug 16, 2022 (view filing) | Aug 15 | 1 day | Gouk WarrenChief Administrative Officer | SSale | −17.2K | $7.85 | −$135.2K | −0.3%6.16M after | |
| Aug 24, 2022 (view filing) | Aug 23 | 1 day | Gouk WarrenChief Administrative Officer | SSale | −17.2K | $7.02 | −$120.9K | −0.3%6.14M after | |
| Sep 8, 2022 (view filing) | Sep 6 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −34.4K | $7.00 | −$241.1K | −0.6%6.11M after | |
| Sep 9, 2022 (view filing) | Sep 8 | 1 day | Gouk WarrenChief Administrative Officer | SSale | −51.7K | $9.01 | −$465.6K | −0.8%6.06M after | |
| Oct 3, 2022 (view filing) | Sep 30 | 3 days | Mullins Kevin MichaelChief Development Officer | SSale | −82.5K | $7.03 | −$580.1K | −1.5%5.58M after | |
| Oct 5, 2022 (view filing) | Oct 3 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −15.1K | $7.02 | −$106.0K | −0.2%6.04M after | |
| Oct 11, 2022 (view filing) | Oct 10 | 1 day | Gouk WarrenChief Administrative Officer | SSale | −15.1K | $7.45 | −$112.5K | −0.2%6.03M after | |
| Oct 19, 2022 (view filing) | Oct 17 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −15.1K | $8.01 | −$121.0K | −0.3%6.01M after | |
| Oct 26, 2022 (view filing) | Oct 24 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −15.1K | $7.06 | −$106.6K | −0.3%6.00M after | |
| Nov 2, 2022 (view filing) | Oct 31 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −15.1K | $7.49 | −$113.1K | −0.3%5.98M after | |
| Nov 9, 2022 (view filing) | Nov 7 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −15.1K | $7.20 | −$108.8K | −0.3%5.97M after | |
| Mar 10, 2023 (view filing) | Mar 8 | 2 days | Mullins Kevin MichaelChief Development Officer | SSale | −122.3K | $6.12 | −$748.4K | −2.1%5.65M after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Mullins Kevin MichaelChief Development Officer | SSale | −800 | $6.11 | −$4.89K | 0.0%5.65M after | |
| Mar 17, 2023 (view filing) | Mar 15-16 | 2 days | Mullins Kevin MichaelChief Development Officer | SSale | −43.9K | $6.14 | −$269.6K | −0.8%5.61M after | 2 lots |
| Apr 4, 2023 (view filing) | Apr 3 | 1 day | Mullins Kevin MichaelChief Development Officer | SSale | −97.3K | $7.43 | −$722.7K | −1.7%5.51M after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Patel-Dunn AnishaChief Medical Officer | SSale | −7.32K | $7.62 | −$55.8K | −2.6%279.7K after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Qureshi Danish J.See Remarks | SSale | −8.78K | $7.62 | −$66.9K | −0.2%4.66M after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Pardo RyanSee Remarks | SSale | −6.40K | $7.62 | −$48.8K | −0.9%686.6K after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Mullins Kevin MichaelChief Development Officer | SSale | −6.40K | $7.62 | −$48.8K | −0.1%5.51M after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Pantaleoni PabloChief Medical Officer | SSale | −6.43K | $7.62 | −$49.0K | −0.6%1.13M after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Gouk WarrenChief Administrative Officer | SSale | −4.79K | $7.62 | −$36.5K | −0.1%6.02M after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Mullins Kevin MichaelChief Development Officer | SSale | −69.7K | $7.61 | −$530.7K | −1.3%5.44M after | |
| Jun 13, 2023 (view filing) | Jun 12 | 1 day | Gouk WarrenChief Administrative Officer | SSale | −2.86K | $8.51 | −$24.3K | 0.0%6.02M after | |
| Jun 14, 2023 (view filing) | Jun 13 | 1 day | Gouk WarrenChief Administrative Officer | SSale | −47.1K | $8.71 | −$410.6K | −0.8%5.97M after | |
| Jun 15, 2023 (view filing) | Jun 14 | 1 day | Gouk WarrenChief Administrative Officer | SSale | −46.0K | $8.95 | −$411.6K | −0.8%5.93M after | |
| Jun 22, 2023 (view filing) | Jun 21 | 1 day | Qureshi Danish J.See Remarks | SSale | −72.4K | $9.03 | −$653.8K | −1.6%4.58M after | 2 lots |
| Jun 23, 2023 (view filing) | Jun 22 | 1 day | Gouk WarrenChief Administrative Officer | SSale | −57.8K | $9.05 | −$522.7K | −1.0%5.87M after | |
| Jun 27, 2023 (view filing) | Jun 26 | 1 day | Pardo RyanSee Remarks | SSale | −50.1K | $8.91 | −$446.7K | −7.3%636.5K after | |
| Jun 27, 2023 (view filing) | Jun 23 | 4 days | Mullins Kevin MichaelChief Development Officer | SSale | −65.8K | $9.02 | −$593.8K | −1.2%5.37M after | |
| Jun 29, 2023 (view filing) | Jun 28 | 1 day | Patel-Dunn AnishaChief Medical Officer | SSale | −2.60K | $9.24 | −$24.0K | −0.9%277.1K after | |
| Jul 6, 2023 (view filing) | Jul 3-5 | 3 days | Mullins Kevin MichaelChief Development Officer | SSale | −204.6K | $8.79 | −$1.80M | −3.8%5.17M after | 2 lots |
| Jul 7, 2023 (view filing) | Jul 6 | 1 day | Mullins Kevin MichaelChief Development Officer | SSale | −135.4K | $8.67 | −$1.17M | −2.6%5.03M after | |
| Aug 25, 2023 (view filing) | Aug 24 | 1 day | Varanakis AnnChief People Officer | SSale | −5.66K | $7.60 | −$43.0K | −3.3%168.4K after | |
| Sep 5, 2023 (view filing) | Aug 31-Sep 1 | 5 days | Gouk WarrenChief Administrative Officer | SSale | −50.0K | $8.25 | −$412.7K | −0.9%5.82M after | 2 lots |
| Oct 3, 2023 (view filing) | Oct 2 | 1 day | Mullins Kevin MichaelChief Development Officer | SSale | −113.3K | $6.61 | −$749.1K | −2.3%4.92M after | |
| Nov 6, 2023 (view filing) | Nov 3 | 3 days | Mullins Kevin MichaelChief Development Officer | SSale | −81.0K | $6.13 | −$496.4K | −1.6%4.84M after | |
| Nov 8, 2023 (view filing) | Nov 6-7 | 2 days | Mullins Kevin MichaelChief Development Officer | SSale | −32.4K | $6.12 | −$198.0K | −0.7%4.80M after | 2 lots |
| Dec 4, 2023 (view filing) | Dec 1 | 3 days | Mullins Kevin MichaelChief Development Officer | SSale | −113.3K | $6.54 | −$741.2K | −2.4%4.69M after |